Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Populations news

Show

From To
Missed HPV vaccination opportunities: a consequence of avoiding awkward conversations

In the US, routine administration of quadrivalent HPV vaccine is recommended for girls and boys at 11-12 yrs, with catch-up vaccination recommended up to 26 yrs for girls, and 21 yrs for boys.  The difficulty has been in the implementation of the recommendation: overall rates of initiating and completion among US teenage girls currently stand at 57% and 35% respectively.

Published
11 November 2014
From
BMJ
Addiction services in England: in need of an intervention

With change comes both opportunity and chaos: an assertion nowhere more true than with England's addiction services. Over the past 5 years, government initiatives to increase cost-effectiveness have opened up bidding for local services to third-party providers. With increased competition, the thinking went, bloated NHS trusts would sharpen their edges and the quality of care would be improved.

Published
10 November 2014
From
The Lancet Psychiatry
Learning, Dating and Hooking Up: Sex Education Goes Online in Cambodia

The transition to puberty can be an awkward experience for youth to navigate. In Cambodia, sex education is moving increasingly into the virtual realm, with the Internet and mobile phones providing welcome spaces for young people to learn, seek help and stay safe.

Published
07 November 2014
From
Inter Press Service
Official drug advisers reject time limit on methadone substitution for addicts

Advisory Council on the Misuse of Drugs says time limits advocated by Iain Duncan Smith would lead to high rates of relapse.

Published
06 November 2014
From
The Guardian
D-day for The Pill for HIV

The media coverage of the unexpectedly early success of two trials of pre-exposure prophylaxis - PrEP - has generally been positive, sometimes overly so. But I haven't seen anything that actually explains why the results of the PROUD and IPERGAY studies are so important, or why they represent a gear-change in the accelerating race towards the end of HIV.

Published
05 November 2014
From
Huffington Post
Half of people with hepatitis C unaware

Dr Vivian Hope of Public Health England said: "With around half of those people living with hepatitis C still unaware of their infection, we need to do more to increase diagnosis rates. Ultimately, this will help reduce the current high level of infection we’re still seeing among people who inject drugs."

Published
05 November 2014
From
Public Health England press release
Dissolving Tampons Deliver HIV Drugs (and Maybe Contraception, Too)

University of Washington researchers have created a discreet, quick-dissolving tampon out of silk-line fibers to protect women from HIV. The researchers would ideally like to develop a tampon to protect against HIV, herpes, and pregnancy — an all-in-one shield against the risks of sex. This could prove especially useful in developing countries, where women may not have easy access to other kinds of birth control.

Published
04 November 2014
From
Healthline News
Namibia’s Highest Court Finds Government Forcibly Sterilised HIV-Positive Women

The case was brought by three HIV-positive women who were subjected to sterilisation without their informed consent in public hospitals. The High Court found in favour of the women and held that the practice of coerced sterilisation violated the women’s legal rights.

Published
04 November 2014
From
Southern Africa Litigation Centre (press release)
HIV testing and ongoing relationships are part of 'safer sex' for young gay men

Many young gay men consider ‘safer sex’ to be about more than condom use, according to a qualitative study conducted in Scotland. Encouragingly, many consider regular HIV

Published
03 November 2014
By
Roger Pebody
Injectable rilpivirine shows promise in phase I trials – but may work better for anal than vaginal sex

A phase one dose-finding and safety study in humans of TMC278 LA, a long-acting, injectable formation of the antiretroviral (ARV) drug rilpivirine, found that a single

Published
01 November 2014
By
Gus Cairns

Filter by country